- Home
- PVBC vs LXRX Comparison
PVBC vs LXRX Comparison
Compare PVBC & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVBC
- LXRX
- Stock Information
- Founded
- PVBC 1913
- LXRX 1995
- Country
- PVBC United States
- LXRX United States
- Employees
- PVBC N/A
- LXRX N/A
- Industry
- PVBC Major Banks
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- PVBC Finance
- LXRX Health Care
- Exchange
- PVBC Nasdaq
- LXRX Nasdaq
- Market Cap
- PVBC 202.6M
- LXRX 228.8M
- IPO Year
- PVBC 2015
- LXRX 2000
- Fundamental
- Price
- PVBC $11.84
- LXRX $0.75
- Analyst Decision
- PVBC Hold
- LXRX Buy
- Analyst Count
- PVBC 1
- LXRX 4
- Target Price
- PVBC $12.50
- LXRX $3.67
- AVG Volume (30 Days)
- PVBC 302.4K
- LXRX 3.7M
- Earning Date
- PVBC 07-28-2025
- LXRX 07-31-2025
- Dividend Yield
- PVBC N/A
- LXRX N/A
- EPS Growth
- PVBC N/A
- LXRX N/A
- EPS
- PVBC 0.26
- LXRX N/A
- Revenue
- PVBC $50,244,000.00
- LXRX $31,213,000.00
- Revenue This Year
- PVBC $9.73
- LXRX N/A
- Revenue Next Year
- PVBC $4.87
- LXRX N/A
- P/E Ratio
- PVBC $45.18
- LXRX N/A
- Revenue Growth
- PVBC N/A
- LXRX 1251.21
- 52 Week Low
- PVBC $9.48
- LXRX $0.28
- 52 Week High
- PVBC $12.96
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- PVBC 64.66
- LXRX 61.01
- Support Level
- PVBC $11.66
- LXRX $0.64
- Resistance Level
- PVBC $11.91
- LXRX $0.77
- Average True Range (ATR)
- PVBC 0.18
- LXRX 0.06
- MACD
- PVBC 0.02
- LXRX 0.00
- Stochastic Oscillator
- PVBC 70.11
- LXRX 76.47
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.